CVE-2023-29144: Malwarebytes · CVE-2023-29144 is a low-severity
Source CVE Database V5
Not known to be exploited · CVSS 3.3 Low.
Data as of 26 Oct 2026, 17:16 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 11% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 12 Dec 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
AI-suggested
- Monitor Malwarebytes official channels for any forthcoming patches or updates addressing CVE-2023-29144 and apply them promptly once available.
- Restrict local access to Linux systems running Malwarebytes to trusted users only, minimizing the risk of low-privilege attackers exploiting this vulnerability.
- Employ additional endpoint detection and response (EDR) tools alongside Malwarebytes to provide layered malware detection capabilities.
- Implement strict application whitelisting and behavior monitoring to detect anomalous activities that might bypass signature-based detection.
- Regularly audit and harden Linux systems to reduce the attack surface and prevent unauthorized local access.
- Conduct periodic security awareness training emphasizing the importance of maintaining endpoint security hygiene and recognizing suspicious activities.
- Use network segmentation to limit potential lateral movement if malware evades detection on one system.
Description
CVE-2023-29144 is a low-severity vulnerability in Malwarebytes 1.0.14 for Linux where improper signature computation allows malware detection bypass. The flaw does not impact confidentiality or availability but can reduce the integrity of the malware detection process. Exploitation requires local access with low privileges and no user interaction is needed. There are no known exploits in the wild, and no patches have been released yet. European organizations using this specific Malwarebytes Linux version could face increased risk of undetected malware infections. Mitigation involves monitoring for updates from Malwarebytes and employing complementary security controls. Countries with higher Linux server usage and Malwarebytes deployment are more likely to be affected. Overall, the threat is limited in scope and impact but should be addressed to maintain endpoint security effectiveness.